NAMS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -0.88, suggesting NAMS is Neutral.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 33.661, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 33.803, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it Sell.

Technical Analysis for NAMS

Technical Sentiment Analysis for NewAmsterdam Pharma Company NV (NAMS) As of 2026-03-10, NewAmsterdam Pharma Company NV (NAMS) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 6 indicators are flashing buy, while 6 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NAMS stands at 42.472, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.88, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 19.61 and the Commodity Channel Index (CCI) at -101.801 further confirm a -4.74 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NAMS is trading above its 60-day moving average of $33.803 and above its 200-day long-term moving average of $29.442. Key price levels to watch include the immediate resistance at $36.334 and strong support at $28.454. A break above $36.334 could signal a bull continuation, while falling below $28.454 may test the next Fibonacci floor at $24.787.

NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	20.574	24.787	28.454	32.667	36.334	40.547	44.214
Fibonacci	24.787	27.797	29.657	32.667	35.677	37.537	40.547

NewAmsterdam Pharma Company NV (NAMS) Technical Indicators

2026-03-10

Name	Value
RSI_14	42.472
STOCHk_14_3_3	19.61
STOCHd_14_3_3	13.845
CCI_20	-101.801
AO_5_34	-3.027
MOM_10	-4.74
MACD_12_26_9	-0.88

NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI) is 42.472, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic Oscillator is 19.61, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic RSI is 13.845, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Commodity Channel Index (CCI) is -101.801, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator is -3.027, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Momentum is -4.74, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) MACD is -0.88, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Moving Average

2026-03-10

Period	Simple	Signal
MA_5	30.644	Buy
MA_10	32.12	Sell
MA_20	33.661	Sell
MA_60	33.803	Sell
MA_200	29.442	Buy
MA_250	27.407	Buy

NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 30.644, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 32.12, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 33.661, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 33.803, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 29.442, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 27.407, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.27, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NAMS?

The overall technical consensus for NewAmsterdam Pharma Company NV (NAMS) is currently Neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 3 sell signals.

What are the key support and resistance levels for NewAmsterdam Pharma Company NV (NAMS) today?

Based on pivot point calculations, NewAmsterdam Pharma Company NV (NAMS) has an immediate support level at 28.454 and a major resistance level at 36.334. Traders also monitor the pivot point at 32.667 to determine the intraday trend direction.

Is NewAmsterdam Pharma Company NV (NAMS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for NewAmsterdam Pharma Company NV (NAMS) is currently 42.472. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for NewAmsterdam Pharma Company NV (NAMS)?

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -0.88, suggesting NAMS is Neutral. This indicator helps identify potential trend reversals or momentum shifts for NewAmsterdam Pharma Company NV.

How is NewAmsterdam Pharma Company NV (NAMS) performing relative to its 200-day moving average?

NewAmsterdam Pharma Company NV (NAMS) is currently trading at $31.27, which is above its 200-day simple moving average of 29.442. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.